XML 29 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Instruments
3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Note 4. Derivative Instruments

The Company uses derivative instruments to manage a variety of risks, including risks related to fluctuations in foreign currency exchange rates and interest rates on debt instruments. We do not use derivative financial instruments for speculative purposes.

The notional amount of the Company's derivatives is summarized as follows (in millions):
 
As of
 
March 31,
2020
 
December 31,
2019
Designated derivatives:
 
 
 
Cash flow hedges
$
526.0

 
$
484.0

Interest rate swap contracts
300.0

 
300.0

Total designated derivatives
826.0

 
784.0

 
 
 
 
Non-designated derivatives
174.4

 
162.9

   Total
$
1,000.4

 
$
946.9



The fair value of derivative instruments on the Consolidated Balance Sheets was as follows:
 
 
 
 
As of
 
 
Balance Sheet Location
 
March 31,
2020
 
December 31,
2019
Derivative assets:
 
 
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
 
 
Foreign currency contracts as cash flow hedges
 
Other current assets
 
$

 
$
2.2

Foreign currency contracts as cash flow hedges
 
Other long-term assets
 
0.1

 
0.3

Interest rate swap designated as fair value hedges
 
Other long-term assets
 
25.6

 

Total derivatives designated as hedging instruments
 
 
 
$
25.7

 
$
2.5

Derivatives not designated as hedging instruments
 
Other current assets
 
1.0

 

Total derivative assets
 
 
 
$
26.7

 
$
2.5

Derivative liabilities:
 
 
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
 
 
Foreign currency contracts as cash flow hedges
 
Other accrued liabilities
 
$
27.6

 
$
6.6

Foreign currency contracts as cash flow hedges
 
Other long-term liabilities
 
4.2

 

Interest rate swap designated as fair value hedges
 
Other long-term liabilities
 

 
3.1

Total derivatives designated as hedging instruments
 
 
 
$
31.8

 
$
9.7

Derivatives not designated as hedging instruments
 
Other accrued liabilities
 
0.6

 
0.2

Total derivative liabilities
 
 
 
$
32.4

 
$
9.9



Designated Derivatives

The Company uses foreign currency forward contracts to hedge the Company's planned cost of revenues and operating expenses denominated in foreign currencies. These derivatives are designated as cash flow hedges. Cash flow hedge derivatives typically have maturities of twenty-four months or less. As of March 31, 2020, an estimated $27.6 million of unrealized net loss within accumulated other comprehensive loss is expected to be reclassified into earnings within the next twelve months.

In 2019, the Company entered into interest rate swaps with an aggregate notional amount of $300.0 million designated as fair value hedges of our fixed-rate 2041 Notes. These swaps convert the fixed interest rates of the notes to floating interest rates based on the LIBOR. Most of the interest rate swaps will expire within ten years or less.

Effect of Derivative Instruments on the Consolidated Statements of Operations

For foreign currency forward contracts, the Company recognized an unrealized loss of $29.1 million and an unrealized gain of $3.4 million in accumulated other comprehensive income for the effective portion of its derivative instruments for the three months ended March 31, 2020 and March 31, 2019, respectively. The losses reclassified out of accumulated other comprehensive income to cost of revenues and operating expenses in the Condensed Consolidated Statements of Operations, were not material during the three months ended March 31, 2020 and March 31, 2019.

Non-Designated Derivatives

The Company also uses foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. These foreign exchange forward contracts typically have maturities of approximately one to four months. The outstanding non-designated derivative instruments are carried at fair value. Changes in the fair value of these derivatives, which were recorded in other expense, net within the Condensed Consolidated Statements of Operations, were not material during the three months ended March 31, 2020 and March 31, 2019.